Since 2013, TI Pharma has embarked on a new phase as an independent non-profit that enables international partnership in drug discovery and development.

A number of projects funded by the government’s gas reserve fund (“FES”), either originating from the 2009 Joint Call (JC) or the 2012 SME Partnership Call (SPC) are still running:  

“TI Pharma's program managers are experts in the content, enabling them to keep parties focused on the goals that were agreed upon at the outset.”

Jan Raaijmakers
Past VP External Scientific Collaborations GSK Europe
Chair TI Pharma Board of Directors

Share this page: